Endocrine surgery claims break on small details: the wrong side on a lobectomy, a nerve monitoring charge the surgeon can't bill, or a completion thyroidectomy sent inside the first operation's global period without the modifier that explains it. Qualigenix codes and bills thyroid, parathyroid, adrenal and pancreatic endocrine surgery, along with the office biopsies and ultrasounds that come before it.
Endocrine surgery billing works by coding the extent of each gland operation from the operative note, applying the 90-day global period, and finalizing the diagnosis once pathology confirms it. Qualigenix's CPC- and CCS-certified coders code thyroid, parathyroid and adrenal cases at 98.9% coding accuracy and run each claim through NCCI checks before submission. Call 786-259-0231 to discuss your caseload.
Thyroid codes split by how much of the gland was removed: partial lobectomy (60210, 60212), total lobectomy (60220, 60225), total thyroidectomy (60240), completion thyroidectomy (60260) and thyroidectomy for malignancy with neck dissection (60252, 60254). The operative note has to state the extent and the side for the code to hold.
Most endocrine surgery is scheduled in advance, so it falls under payer prior authorization rules. Localization imaging, inpatient stays and robotic approaches can each need their own approval.
Intraoperative nerve monitoring codes (95940, 95941 and G0453) can't be billed by the operating surgeon, an assistant surgeon or the anesthesiologist. They're payable only to a separate monitoring professional, and monitoring the surgeon does is part of the surgical package.
Thyroid nodule work-ups often happen in the office, with ultrasound-guided fine-needle aspiration (10005, 10006) and diagnostic neck ultrasound (76536). The imaging guidance is included in the guided FNA code, and a same-day E/M visit needs modifier 25 and a separately documented evaluation.
Outpatient thyroid surgery and inpatient adrenal or pancreatic surgery can fall under different benefit rules on the same plan. Verification has to match the setting the surgeon has planned.
The pre-op diagnosis is often a thyroid nodule (E04.1), and pathology may confirm cancer (C73) or a benign finding. Outpatient coding rules don't allow an uncertain diagnosis to be coded as confirmed, so the final code should follow the signed pathology report.
A return to the operating room for a neck hematoma falls in the 90-day global period and takes modifier 78. A completion thyroidectomy after cancer is found on final pathology is a staged procedure and takes modifier 58 when it falls inside the global period.
NCCI bundles many endocrine procedure pairs, and Medicare's fee schedule marks which codes allow an assistant surgeon. An assistant claim (modifier 80 or 82) on a code that doesn't allow one is denied no matter what the note says.
Qualigenix matches each gap above with a step its coders complete before the claim is sent.
Coders read the extent, side and approach from the operative note and query the surgeon when the note is unclear.
We request authorization for the procedure, imaging and setting together when the case is scheduled, and track each approval's end date.
Nerve monitoring codes are kept off the surgeon's claim, and any monitoring charge is confirmed to belong to a separate monitoring provider.
Office FNA and ultrasound are coded under the guidance rules, and same-day E/M visits are billed only when the note supports a separate evaluation.
Benefits are verified for the planned setting, inpatient or outpatient, before the surgery is booked.
The final diagnosis on the surgical claim follows the signed pathology report, not the pre-op impression.
Denials for completion surgery and returns to the operating room are appealed with the pathology report or complication notes attached. Qualigenix overturns 79% of the denials it works.
Internal audits test procedure pairs and assistant claims against NCCI and the Medicare fee schedule, with a 98.6% audit pass rate.
A 3-provider podiatry group with roughly 60% Medicare payer mix carried $412,000 in A/R, 38% of it past 120 days. Routine foot care claims (11720, 11721, 11055–11057) had stalled on inconsistent Q7/Q8/Q9 modifiers and class-finding documentation, so payers held or partially paid and nobody worked the remainder. Medicare crossover to secondaries was not being posted, and small patient balances were written off.
We ran a full A/R aging segmentation, worked claims by payer and denial reason rather than by date, rebilled the stalled routine-care claims with corrected modifiers, and reactivated secondary and crossover billing.
A solo podiatrist coding 320 encounters a month was stuck at 82% first-pass acceptance. Routine foot care went out without the systemic-condition diagnosis pairing and class findings Medicare requires, so it read as non-covered. Wound debridement was coded to the wrong depth (11042 for skin and subcutaneous where the note supported 11043 for muscle and fascia). Same-day E/M with a procedure went out without modifier 25 and got bundled.
We rebuilt the coding workflow: diagnosis-to-CPT pairing rules for at-risk foot care, correct Q-modifier logic, depth-based debridement coding tied to the operative note, and disciplined use of modifiers 25 and 59/XS.
A 2-location podiatry practice sat at a 19% denial rate, mostly Medicare routine-foot-care and nail-debridement rejections. The denials clustered in three buckets: medical-necessity rejections on routine foot care (missing qualifying diagnosis and class findings), frequency-edit denials on nail debridement billed inside the 60-day window, and missing Q modifiers that flagged services as non-covered.
We built a front-end denial-prevention layer, checking eligibility and coverage against payer LCDs before claims went out, plus a structured appeal workflow with documentation templates mapped to each denial reason.
Endocrine surgery codes are organized by gland, then by extent and approach.
Thyroid codes run from partial lobectomy to substernal thyroidectomy. 60270 and 60271 cover substernal glands removed by a sternal split or a cervical approach, and 60252 and 60254 add neck dissection for malignancy.
Endocrine surgery practices General surgery groups Head and neck surgical centers Academic surgical programs Multi-specialty surgical networks

Qualigenix charges a percentage of collections, so the fee moves with what your practice is paid. The percentage depends on volume and scope and is quoted after we review your claim mix. Call 786-259-0231 to start that conversation.
A completion thyroidectomy is 60260, with the side marked. Inside the first operation's 90-day global period, it takes modifier 58 when it's the planned next step after pathology.
Coders match each code to the documented extent and side, keep nerve monitoring off the surgeon's claim and check NCCI pairs before submission. Qualigenix holds a 98.6% audit pass rate.
Yes. We work open surgical claims by age, payer and denial reason, starting with the oldest balances. Qualigenix's A/R work has cut days in A/R from 54 to 36.
No. Intraoperative nerve monitoring (95940, 95941 or G0453) can't be billed by the operating surgeon or an assistant surgeon, and the surgeon's own monitoring is part of the surgical package. Only a separate monitoring professional can bill it.
Yes. We code ultrasound-guided FNA (10005, 10006) with the guidance included, bill a diagnostic neck ultrasound (76536) only with its own report, and add a same-day E/M visit only when the note supports a separate evaluation.
Yes. Qualigenix works in the EHR and practice management system you already use and has worked across 133 EMR and EHR platforms.
Qualigenix onboards new practices in 6 days on average. Call 786-259-0231 to plan your start date.